NASDAQ:VKTX

Viking Therapeutics Stock Predictions

etoro logo Buy VKTX
*Your capital is at risk
$29.33
+0.0400 (+0.137%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

VKTX Prediction Chart

VKTX Predictions History

Latest community submissions for VKTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Sep 23, 2025 $25.79 -1.74% $24.97 V 96.71% 1
Sep 23, 2025 Bullish $24.97 X 0
Sep 19, 2025 $25.33 -2.74% $25.40 V 99.71% 5
Sep 19, 2025 $25.59 -1.71% $25.40 V 99.24% 3
Sep 19, 2025 $26.90 +3.30% $25.40 X 94.09% 0
Sep 18, 2025 $23.76 +2.92% $26.04 V 91.26% 1
Sep 18, 2025 $23.51 +1.82% $26.04 V 90.29% 1
Sep 18, 2025 $25.00 +8.27% $26.04 V 96.01% 1
Sep 18, 2025 Bearish $26.04 X 0
Sep 17, 2025 $24.38 +2.90% $23.09 X 94.42% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VKTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VIKING THERAPEUTICS
Viking Therapeutics
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also dev...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE